1 / 6

Pulmonary Drug Delivery Devices Market: Status and Forecast, by Players, Types and Applications

Global pulmonary drug delivery devices market was valued at approximately US$ 35,000 Mn in 2017; which is anticipated to reach a value of nearly US$ 46,000 Mn by 2026, expanding at a CAGR of about 3.0% from 2018 to 2026.

pharmahealth
Download Presentation

Pulmonary Drug Delivery Devices Market: Status and Forecast, by Players, Types and Applications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Pulmonary Drug Delivery Devices Market Product - Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers; Application - Asthma, COPD, Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, E-commerce Forecast From 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Analysis, by Component Chapter 6 Market Analysis, by Data Type Chapter 7 Market Analysis, by Application Chapter 8 Market Analysis, by Region Chapter 9 Competition Landscape Chapter 10 Company Profiles Chapter 11 Key Takeaways

  3. ©2019 Transparency Market Research, All Rights Reserved Pulmonary Drug Delivery Devices Market: Snapshot • The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non- pulmonary diseases • Increase in prevalence and incidence of respiratory diseases, increasing population of smokers, rise in prescription of combination therapies, digitalization of respiratory inhaler devices, increase in geriatric population, high unmet needs, high R&D in asthma and COPD treatment, and rise in number of awareness programs are likely to drive the global pulmonary drug delivery devices market. • global pulmonary drug delivery devices market has been segregated into asthma, COPD, cystic fibrosis, and others. ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights • global pulmonary drug delivery devices market was valued at approximately US$ 35,000 Mn in 2017. It is anticipated to reach a value of nearly US$ 46,000 Mn by 2026, expanding at a CAGR of about 3.0% from 2018 to 2026. • Major players - • GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Koninklijke Philips N.V., 3M Healthcare, Omron Corporation, F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co. Request Sample ©2019 Transparency Market Research, All Rights Reserved

  6. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related